Metraipolis › archive › dc_7ac5964ea3a8

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist… — Europe PMC PMID:37777766

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37777766
DOI
10.1186/s13011-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-08T14:01:14.828Z
SHA-256 of the archived text
42e13f62293d308f343792fb3a6e40f3e6f0e42fe8e321545e955aef8ae9da13
Stable URL of this page
https://metraipolis.com/documento/dc_7ac5964ea3a8

How to cite

The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist… — Europe PMC PMID:37777766 — Europe PMC (en), https://europepmc.org/article/MED/37777766 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ac5964ea3a8 (Metraipolis archive dc_7ac5964ea3a8, sha256 42e13f62293d308f343792fb3a6e40f3e6f0e42fe8e321545e955aef8ae9da13)
BibTeX
@misc{dc7ac5964ea3a8,
  title = {The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist… — Europe PMC PMID:37777766},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37777766},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ac5964ea3a8; sha256 42e13f62293d308f343792fb3a6e40f3e6f0e42fe8e321545e955aef8ae9da13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37777766. Agents can read the archived copy with the MCP tool read_document.